MAPK pathway |
NM2337
|
Breast |
1-Phosphorylation of KSR leading to reduced ERK1/2 activation |
Reduces both experimental & spontaneous metastases |
|
|
Melanoma163–165
|
|
|
|
|
|
2-LPA signaling54
|
|
|
|
Colon166,167
|
|
|
|
|
Oral36,168
|
|
|
|
RKIP60
|
Prostate |
Inhibits RAF mediated MAP/ERK kinase phosphorylation |
Reduces spontaneous metastases |
|
MKK466,70,71,72
|
Prostate, ovarian cancer |
MAP2K activates p38 and/or JNK |
Reduces spontaneous metastases |
|
MKK666
|
Ovarian cancer |
Activates MAPK p38 |
Reduces experimental metastases |
|
MKK772
|
Prostate cancer |
Activates MAPK JNK |
Reduces spontaneous metastases |
Adhesion proteins |
KAI1169–171
|
Prostate |
Cell adhesion and Integrin signaling |
Reduces spontaneous metastases |
|
CD4489,172,173,174,175
|
Prostate |
Affects cellular adhesion by hyaluronic acid and osteopontin signaling |
Reduces spontaneous metastasis |
|
E-cadherin176,177,178,179
|
Colon, pancreatic and ovarian cancer |
Ca2+ dependent cell adhesion |
Reduces spontaneous metastases |
Cytoskeletal signaling |
Gelsolin106
|
Melanoma |
Actin-regulatory protein helping in actin polymerization |
Reduces spontaneous metastasis |
|
Rho-Rac pathway: RhoGDI2109
|
Bladder cancer |
Rho-Rac signaling |
Reduces experimental metastasis |
|
DLC-1111
|
Breast cancer |
Rho GTPase activating protein which affects cytoskeletal remodeling |
Reduces spontaneous metastasis |
G-protein-coupled receptors pathway |
KISS1114,115
|
Melanoma |
Cytoskeletal reorganization |
Reduces both experimental and spontaneous metastases |
|
|
Breast116
|
|
|
|
|
Lungs |
|
|
|
Protein kinase A/C pathway: SSeCKS/Gravin/AKAP12120,121,180
|
Prostate cancer |
PKA-mediated activation of Src kinase |
Reduces spontaneous metastasis |
Apoptotic pathway |
Caspase-8123,181,182
|
Neuroblastoma |
Increases integrin-mediated cell death |
Reduces spontaneous metastasis |
|
GAS1124,183
|
Melanoma |
Induces apoptosis through caspases 3 and 9 |
Reduces spontaneous metastasis |
Transcriptional complexes |
BRMS1184,185
|
Melanoma, ovarian cancer |
Chromatin remodeling (polyubiquitinated p300, a histone acetyltransferase) and PI3K signaling |
Reduces spontaneous metastasis |
|
MYC141
|
Breast cancer |
Transcriptional silencing of αv and β3 integrin subunits |
Reduces spontaneous metastasis |
Anti-metastatic miRNAs (Metastamirs) |
miR-146a/b147,186
|
Breast cancer |
Reduces NFκB and EGFR pathway |
Reduces experimental metastasis |
|
miR-206 |
Breast cancer |
Target transcription factor S0X4 and extracellular matrix component tenascin C |
Reduces experimental metastasis |
|
miR-335148
|
|
|
Long non-coding RNA (lncRNA) |
LncRNA LET153,154
|
Hepatocellular carcinoma and colon carcinoma |
Binds to NF90 and causes its degradation |
Reduces experimental metastasis |
|
NKILA (NFκB-activating lncRNA)155,156
|
Breast cancer |
Negative regulator of NFκB signaling |
Reduces experimental metastasis |
Metastasis susceptibility genes |
Cadm1160
|
Breast cancer |
Sensitizes tumor cells to immune-surveillance mechanisms by CD8+ T cells |
Reduces spontaneous metastasis |